CD14 and chronic kidney disease: CKD patients and hemodialysis (HD) patients have a higher percentage of intermediate monocytes (CD14++CD16+) in the circulation compared to healthy subjects6,7 and this specific monocyte subtype has been associated with increased cardiovascular events and progression of anemia in CKD8,9.